Gitnux/Report 2026

Space Medicine Industry Statistics

The global space medicine market reached $1.5 billion in 2026, explore the figures behind growth, companies, and operational trends in orbital medicine.
6Statistics
22Sources
1Sections
12mRead
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The space medicine industry at a glance

The global space medicine market reached $1.5 billion in 2026, with growth driven by commercial spaceflight, space tourism, AI health monitoring, telemedicine and regenerative-medicine research.

$1.5B[1]
Market size, 2026
12.8%[1]
Forecast CAGR, 2026–2030
$2.4B[1]
Forecast market size, 2030
6th[4]
Private ISS mission awarded, 2026
Market size
The global space medicine market was valued at $1.33 billion in 2025 and reached an estimated $1.5 billion in 2026. The market includes medical screening, in-flight monitoring, telemedicine, countermeasures, rehabilitation, space-adapted devices, pharmaceuticals and diagnostic tools.[1]
Forecast & CAGR
The market is forecast to reach $2.4 billion by 2030, representing a 12.5% CAGR from 2025 to 2030 or a 12.8% CAGR from 2026 to 2030, depending on the stated base year. Growth is linked to commercial spaceflight, space tourism, AI-based monitoring, private astronaut health programs and remote diagnostics.[1]
Market share & regions
North America was the largest regional market in 2025, while Asia-Pacific was identified as the fastest-growing region. The report covers seven regional markets: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.[1]
Segmentation
The market is segmented by type into private and non-private aerospace services; by technology into telemedicine, AI and machine-learning health monitoring, and remote diagnostics; by application into regenerative medicine, neurobiology and microbiology; and by end user into commercial, government and military customers.[1]
Key players & concentration
The 2026 market report profiles 20 companies, including Boeing, Lockheed Martin, Collins Aerospace, KBR, Axiom Space, Sierra Space, Redwire, Varda Space Industries, Nanoracks, SpacePharma, rHEALTH and Virgin Galactic. No reliable public source identified a defensible percentage concentration measure for the space medicine market.[1]
Trends, drivers & challenges
Commercial spaceflight and space tourism are expanding demand for medical screening, emergency care, behavioral-health support and onboard monitoring. Key technical challenges remain microgravity, radiation, isolation, limited medical resources and the need to support longer-duration missions; Varda’s 2026 W-7 mission also illustrates the push toward pharmaceutical production and testing in microgravity.[1][5]
Consumer behavior & competition
A 2023 Pew Research Center survey of 10,329 U.S. adults, cited by The Business Research Company, found that 55% expected space tourism to become routine by 2073 and 35% were personally interested in going to space. Competition spans established aerospace contractors, commercial-space operators, private-station developers and specialist biomedical companies rather than a single dominant provider.[1][6]
Regulation
In the United States, the FAA licenses commercial launches and reentries, verifies vehicles intended to carry humans and regulates flight-crew qualifications, while congressional limits restrict direct FAA regulation of occupant safety until the current moratorium expires on January 1, 2028. FAA rules require informed consent, disclosure of risks and verification that a vehicle performs as intended before spaceflight participants may fly.[7][8]
Latest news
In October 2026, Varda Space Industries launched its W-7 spacecraft to test whether microgravity could produce improved crystals for PROTAC cancer medicines. In February 2026, NASA selected Vast for the sixth private astronaut mission to the International Space Station, targeted for no earlier than summer 2027, broadening the commercial market for crew-health and space-medicine services.[5][4]

02 Ranking

Top 10 Companies in the Space Medicine Industry

The leading companies in the space medicine industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Varda Space Industries stands out for in-orbit pharmaceutical processing and Earth sample return because it builds spacecraft for that purpose, while Axiom Space focuses on human spaceflight systems since it operates private astronaut missions and develops next-generation spacesuits.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in in-orbit pharma processing

    Varda Space Industries

    US

    Ranked #1 · 9.6 · In-orbit pharma processing

    Why we picked it: Its in-orbit processing and returned samples focus the category on pharmaceutical work in microgravity.

  2. Leader in crew missions and suits

    Axiom Space

    US

    Ranked #2 · 9.1 · Crew missions and suits

    Why we picked it: Crew-health research and human-rated systems align with medical screening and in-flight monitoring demand.

  3. Leader in orbital lab operations

    Vast

    US

    Ranked #3 · 8.5 · Orbital lab operations

    Why we picked it: Its lab activity ties microgravity bioproduction to regenerative medicine and space-based tissue models.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the space medicine industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Varda Space Industries

In-orbit pharma processing · US

9.6
2

Axiom Space

Crew missions and suits · US

9.1
3

Vast

Orbital lab operations · US

8.5
4

Voyager Technologies

Recurring orbital biotech integration · US

8.3
5

Exobiosphere

High-throughput microgravity screening · LU

8.2
6

Yuri

Space biotech platforms and life-science mission services · DE

7.9
7

SpacePharma

Miniaturized pharmaceutical labs and microgravity experiments · CH

7.7
8

Space LiinTech

Space-based biopharma platforms and orbital manufacturing · KR

7.6
9

Space Tango

Automated microgravity research and biomanufacturing systems · US

7.6
10

Eascra Biotech

Space-enabled nanomedicine and therapeutic delivery · US

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the space medicine industry. In Space Medicine Industry Statistics. Gitnux. https://gitnux.org/space-medicine-industry-statistics/#top-companies

04 Statistics

Market Intelligence

We separate market totals from the services and technologies used for human spaceflight. In 2026, the category spans an estimated $1.5 billion total and $1.14 billion in services for medical assessment and support.

Market size and service revenue in the space medicine industry

  • $1.33 billion was the global 2025 space medicine market, defined as revenues from pre-flight screening, in-flight monitoring, telemedicine, countermeasures, radiation protection, psychological support, rehabilitation and related services.[1]
  • $1.055 billion was the estimated global 2026 space medicine market, covering medical technologies and services for human spaceflight and related astronaut-health needs.[2]
  • $1.14 billion was the estimated global 2026 space medicine services market, covering medical assessment and support for people participating in space activities.[3]

Growth forecasts for the space medicine industry

  • The global space medicine services market is projected to reach $2.22 billion by 2034 from $1.14 billion in 2026, representing an 8.7% CAGR for medical assessment and support services.[3]
  • The global space medicine market is projected to reach $2.218 billion in 2033 from $1.055 billion in 2026, representing an 11.2% CAGR for medical technologies and services supporting human spaceflight.[2]
  • The global space medicine market is projected to reach $2.4 billion by 2030 from $1.33 billion in 2025, a 12.5% CAGR; the study defines the category around astronaut health and space-mission medical services.[1]

Key questions about the space medicine industry

What is the 2026 market size for space medicine?
The global space medicine market reached an estimated $1.5 billion in 2026, up from $1.33 billion in 2025.
How fast is the space medicine market growing through 2030?
The market is forecast to reach $2.4 billion by 2030. That implies a 12.5% CAGR from 2025 to 2030 or a 12.8% CAGR from 2026 to 2030.
Which companies lead the space medicine industry?
Varda Space Industries stands out for in-orbit pharmaceutical processing and Earth sample return because it builds spacecraft for that purpose, while Axiom Space focuses on human spaceflight systems since it operates private astronaut missions and develops next-generation spacesuits.
What technology shifts show up most in 2026–2030 forecasts?
Growth drivers include AI health monitoring and telemedicine, alongside regenerative-medicine research. The trend list also points to AI-guided diagnostics moving toward autonomy and wearable monitoring increasing.
How is the market structured by services and technology?
The market covers medical technologies and services for human spaceflight and astronaut-health needs, and it is also segmented by technology into telemedicine, AI health monitoring, and remote diagnostics.
How do private ISS missions affect space medicine demand in 2026?
In 2026, 6th private ISS mission was awarded, and that broadens crew-health and space-medicine services. In February 2026, NASA selected Vast for that sixth private astronaut mission.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Space Medicine Industry Statistics. Gitnux. https://gitnux.org/space-medicine-industry-statistics
MLA
Samuel Norberg. "Space Medicine Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/space-medicine-industry-statistics.
Chicago
Samuel Norberg. 2026. "Space Medicine Industry Statistics." Gitnux. https://gitnux.org/space-medicine-industry-statistics.